TNGX Tango Therapeutics, Inc.

Fundamentals / CIK 0001819133 / USD

Tango Therapeutics, Inc. reported $0 in revenue and a net loss of $208.0M for the trailing twelve months ended September 30, 2026 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TNGX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$75.25M$37.62M$0-$127.1MFY 2020 Revenue: $7.66MFY 2020 Net Income: -$51.97M2020FY 2021 Revenue: $37.04MFY 2021 Net Income: -$58.23M2021FY 2022 Revenue: $24.86MFY 2022 Net Income: -$108.2M2022FY 2023 Revenue: $36.53MFY 2023 Net Income: -$101.7M2023FY 2024 Revenue: $42.07MFY 2024 Net Income: -$130.3M2024FY 2025 Revenue: $62.38MFY 2025 Net Income: -$101.6M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $62.38M $42.07M $36.53M $24.86M $37.04M $7.66M
Research & Development $132.2M $143.9M $115.2M $105.9M $77.64M $49.99M
Total Operating Expenses $173.7M $187.7M $150.7M $135.9M $95.23M $59.86M
Operating Income -$111.3M -$145.6M -$114.2M -$111.1M -$58.19M -$52.20M
EBITDA -$109.0M -$143.1M -$111.8M -$109.5M -$57.29M -$51.48M
Income Before Tax -$101.6M -$130.1M -$101.6M -$108.1M -$57.94M -$51.97M
Income Tax Expense $4.0K $208K $134K $54K $292K $0
Net Income -$101.6M -$130.3M -$101.7M -$108.2M -$58.23M -$51.97M
Basic EPS -$0.87 -$1.19 -$1.08 -$1.23 -$0.94 -$1.63
Diluted EPS -$0.87 -$1.19 -$1.08 -$1.23 -$0.94 -$1.63
Basic Shares Outstanding 116.2M 109.2M 94.6M 87.8M 62.1M 31.9M
Diluted Shares Outstanding 116.2M 109.2M 94.6M 87.8M 62.1M 31.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $0 $0 $0 $0 $53.81M $3.18M $5.39M $4.12M
Research & Development $48.93M $37.20M $33.53M $32.10M $30.82M $32.81M $36.44M $33.94M
Total Operating Expenses $78.12M $59.78M $48.77M $41.86M $39.74M $44.15M $47.92M $45.03M
Operating Income -$78.12M -$59.78M -$48.77M -$41.86M $14.07M -$40.97M -$42.53M -$40.91M
EBITDA -$77.70M -$59.36M -$48.31M -$41.38M $14.63M -$40.34M -$41.91M -$40.29M
Income Before Tax -$68.39M -$55.34M -$45.51M -$38.80M $15.87M -$38.82M -$39.84M -$37.62M
Income Tax Expense $0 $1.0K $1.0K -$55K -$10K $35K $34K $49K
Net Income -$68.39M -$55.34M -$45.51M -$38.75M $15.88M -$38.85M -$39.88M -$37.67M
Basic EPS -$0.39 -$0.37 -$0.32 -- $0.14 -$0.35 -$0.36 --
Diluted EPS -$0.39 -$0.37 -$0.32 -- $0.13 -$0.35 -$0.36 --
Basic Shares Outstanding 173.9M 149.9M 143.6M -- 111.0M 110.5M 110.3M --
Diluted Shares Outstanding 173.9M 149.9M 143.6M -- 117.8M 110.5M 110.3M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $112.3M $69.53M $66.39M $59.97M $142.7M $28.38M
Short-Term Investments $230.9M $188.4M $270.5M $306.2M $342.5M $161.9M
Cash & Short-Term Investments $343.1M $257.9M $336.9M $366.1M $485.3M $190.3M
Accounts Receivable, Net -- -- -- $2.00M $2.00M $2.00M
Total Current Assets $353.8M $266.3M $346.5M $375.3M $492.3M $193.6M
Property, Plant & Equipment, Net $6.87M $8.10M $9.91M $10.88M $4.83M $3.82M
Other Non-Current Assets $303K $4.0K $46K $5.0K $19K $38K
Total Non-Current Assets $44.93M $50.15M $56.03M $61.20M $7.82M $13.62M
Total Assets $398.7M $316.5M $402.6M $436.5M $500.2M $207.3M
Accounts Payable $1.18M $1.60M $2.79M $4.45M $3.23M $1.84M
Deferred Revenue (Current) $0 $17.62M $25.67M $31.79M $26.02M $31.98M
Total Current Liabilities $21.68M $38.17M $45.94M $55.55M $40.69M $40.92M
Deferred Revenue (Non-Current) $0 $44.77M $66.68M $92.09M $114.7M $120.8M
Other Non-Current Liabilities -- -- -- -- -- $5.0K
Total Non-Current Liabilities $30.83M $78.81M $103.5M $131.4M $114.7M $127.7M
Total Liabilities $52.51M $117.0M $149.5M $187.0M $155.4M $168.7M
Total Debt (incl. Leases) $33.57M $36.49M $36.49M $41.13M $1.50M $7.88M
Common Stock $136K $108K $102K $88K $88K $40K
Retained Earnings -$603.2M -$501.6M -$371.3M -$269.5M -$161.3M -$103.1M
Accumulated Other Comp. Income $224K $336K $186K -$3.71M -$765K $17K
Total Stockholders' Equity $346.2M $199.5M $253.1M $249.5M $344.7M $38.60M
Total Equity $346.2M $199.5M $253.1M $249.5M $344.7M $38.60M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $86.83M $345.6M $157.8M $112.3M $58.34M $58.34M $58.43M $69.53M
Short-Term Investments $890.7M $668.4M $222.0M $230.9M $94.47M $141.5M $158.3M $188.4M
Cash & Short-Term Investments $977.5M $1.00B $379.8M $343.1M $152.8M $180.8M $216.7M $257.9M
Total Current Assets $992.7M $1.03B $392.3M $353.8M $163.8M $190.1M $224.9M $266.3M
Property, Plant & Equipment, Net $5.75M $6.09M $6.38M $6.87M $7.35M $7.79M $7.54M $8.10M
Other Non-Current Assets $246K $312K $293K $303K $290K $310K $1.0K $4.0K
Total Non-Current Assets $40.80M $42.21M $43.47M $44.93M $46.36M $47.79M $49.38M $50.15M
Total Assets $1.03B $1.07B $435.8M $398.7M $210.1M $237.9M $274.3M $316.5M
Accounts Payable $1.65M $1.81M $2.43M $1.18M $2.23M $2.61M $3.24M $1.60M
Deferred Revenue (Current) -- -- -- $0 $0 $23.37M $19.48M $17.62M
Total Current Liabilities $25.16M $20.30M $14.33M $21.68M $18.44M $40.02M $35.92M $38.17M
Deferred Revenue (Non-Current) -- -- -- $0 $0 $30.44M $37.51M $44.77M
Total Non-Current Liabilities $28.12M $29.05M $29.96M $30.83M $31.66M $62.91M $71.63M $78.81M
Total Liabilities $53.29M $49.35M $44.29M $52.51M $50.10M $102.9M $107.5M $117.0M
Total Debt (incl. Leases) $31.18M $31.99M $32.79M $33.57M $34.76M $35.01M $36.95M $36.49M
Common Stock $169K $168K $144K $136K $112K $111K $108K $108K
Retained Earnings -$772.4M -$704.0M -$648.7M -$603.2M -$564.4M -$580.3M -$541.4M -$501.6M
Accumulated Other Comp. Income -$4.51M -$633K -$115K $224K $121K $94K $194K $336K
Total Stockholders' Equity $980.2M $1.02B $391.5M $346.2M $160.0M $135.0M $166.8M $199.5M
Total Equity $980.2M $1.02B $391.5M $346.2M $160.0M $135.0M $166.8M $199.5M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$101.6M -$130.3M -$101.7M -$108.2M -$58.23M -$51.97M
Depreciation & Amortization $2.28M $2.50M $2.42M $1.61M $897K $718K
Stock-Based Compensation $26.43M $28.90M $19.08M $14.23M $7.83M $1.76M
Change in Receivables -- -- $2.00M -- -- -$2.00M
Change in Payables -$825K -$1.18M -$1.71M $1.10M $1.23M $1.17M
Operating Cash Flow -$138.9M -$131.5M -$118.0M -$109.1M -$59.53M $70.07M
Capital Expenditure -$1.05M -$754K -$1.53M -$7.69M -$1.84M -$1.11M
Free Cash Flow -$139.9M -$132.3M -$119.5M -$116.8M -$61.36M $68.97M
Purchases of Investments -$264.5M -$240.9M -$310.6M -$208.5M -$372.4M -$207.5M
Investing Cash Flow -$40.87M $86.13M $41.43M $26.40M -$183.4M -$145.5M
Financing Cash Flow $222.5M $47.66M $82.41M $1.61M $357.3M $80.88M
Net Change in Cash $42.75M $2.29M $5.85M -$81.07M $114.4M $5.49M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$68.39M -$55.34M -$45.51M -$38.75M $15.88M -$38.85M -$39.88M -$37.67M
Depreciation & Amortization $420K $425K $463K $479K $555K $625K $622K $620K
Stock-Based Compensation $24.91M $16.89M $10.80M $5.98M $6.62M $6.57M $7.25M $7.46M
Change in Payables -$160K -$759K $1.78M -$1.23M -$344K -$880K $1.63M -$2.51M
Operating Cash Flow -$37.14M -$38.87M -$44.36M -$29.72M -$30.95M -$36.52M -$41.70M -$36.65M
Capital Expenditure -$77K $20K $2.0K -$222K -$151K -$624K -$51K -$124K
Free Cash Flow -$37.22M -$38.85M -$44.36M -$29.94M -$31.10M -$37.14M -$41.75M -$36.77M
Purchases of Investments -$301.5M -$519.1M -$54.41M -$175.0M -$18.34M -$23.94M -$47.16M -$32.55M
Investing Cash Flow -$224.0M -$446.0M $9.63M -$135.7M $47.48M $16.78M $30.60M $52.06M
Financing Cash Flow $2.40M $672.6M $79.85M $219.4M $2.54M $581K $2.0K $969K
Net Change in Cash -$258.7M $187.7M $45.12M $53.94M $19.07M -$19.16M -$11.10M $16.38M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -178.4% -346.1% -312.6% -446.8% -157.1% -681.8%
Net Profit Margin -162.9% -309.7% -278.5% -435.1% -157.2% -678.8%
Return on Equity (ROE) -29.3% -65.3% -40.2% -43.4% -16.9% -134.6%
Return on Assets (ROA) -25.5% -41.2% -25.3% -24.8% -11.6% -25.1%
Current Ratio 16.32x 6.98x 7.54x 6.76x 12.10x 4.73x
Quick Ratio 15.83x 6.76x 7.33x 6.63x 11.97x 4.70x
Debt to Equity 0.10x 0.18x 0.14x 0.16x 0.00x 0.20x
Revenue Growth (YoY) +48.3% +15.2% +46.9% -32.9% +383.8% --
Operating Cash Flow Growth (YoY) -- -- -- -- -184.9% --
Free Cash Flow Growth (YoY) -- -- -- -- -189.0% --
5Y Revenue / Share Growth +124.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -- -253.4% -206.2% -178.4% -165.9% -647.3% -355.9% -346.1%
Net Profit Margin -- -229.9% -188.2% -162.9% -151.1% -599.1% -322.7% -309.7%
Return on Equity (ROE) -21.2% -12.1% -27.4% -29.3% -62.8% -107.9% -79.3% -65.3%
Return on Assets (ROA) -20.1% -11.5% -24.6% -25.5% -47.8% -61.2% -48.2% -41.2%
Current Ratio 39.45x 50.82x 27.38x 16.32x 8.88x 4.75x 6.26x 6.98x
Quick Ratio 38.85x 49.26x 26.50x 15.83x 8.28x 4.52x 6.03x 6.76x
Debt to Equity 0.03x 0.03x 0.08x 0.10x 0.22x 0.26x 0.22x 0.18x
Revenue Growth (YoY) -100.0% -100.0% -100.0% -100.0% +363.6% -84.0% -16.7% -24.2%
Operating Income Growth (YoY) -655.1% -- -- -- -- -- -- --
Net Income Growth (YoY) -530.6% -- -- -- -- -- -- --
EPS Growth (YoY) -378.6% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001819133) · from March 31, 2020 Data through September 30, 2026 · synced Nov 20, 2026, 05:18 UTC · Open in terminal